Abbott Laboratories (NYSE: ABT) Q3 2026 Earnings: Key Financials and Strategic Outlook
Abbott Laboratories (NYSE: ABT) reported mixed Q3 2026 financial results, with adjusted earnings per share matching estimates and revenue slightly exceeding expectations. Despite strong overall sales growth, Abbott reaffirmed its full-year earnings guidance but revised its 2026 sales growth…